The pancreatic islet β-cell autoantigen of relative molecular mass 64,000 (64K), which is a
major target of autoantibodies associated with the development of insulin-dependent diabetes …

Islet cell autoantigen (ICA) 512 is a novel autoantigen of insulin‐dependent diabetes
mellitus (IDDM) which is homologous to receptor‐type protein tyrosine phosphatases (++PTPases). …

We report the identification of βIV spectrin, a novel spectrin isolated as an interactor of the
receptor tyrosine phosphatase-like protein ICA512. The βIV spectrin gene is located on human …

Stiff-man syndrome is a rare disorder of the central nervous system of unknown pathogenesis.
We have previously reported the presence of autoantibodies against glutamic acid …

Generation and turnover of phosphoinositides (PIs) must be coordinated in a spatial- and
temporal-restricted manner. The small GTPase Rab5 interacts with two PI 3-kinases, Vps34 …

Transplantation of pancreatic islets is emerging as a successful treatment for type-1 diabetes.
Its current stringent restriction to patients with critical metabolic lability is justified by the …

Pancreatic β-cells store insulin in secretory granules that undergo exocytosis upon glucose
stimulation. Sustained stimulation depletes β-cells of their granule pool, which must be …

Aims/hypothesis Pancreatic islet beta cell failure causes type 2 diabetes in humans. To
identify transcriptomic changes in type 2 diabetic islets, the Innovative Medicines Initiative for …

The discovery of insulin in 1921 has been one of greatest scientific achievements of the
20th century. Since then, the availability of insulin has shifted the focus of diabetes treatment …

Islet cell autoantigen 512 (ICA512)/IA-2 is a receptor tyrosine phosphatase-like protein
associated with the insulin secretory granules (SGs) of pancreatic β-cells. Here, we show that …